A team of investigators assessed the frequency with which patients with type 2 diabetes and heart failure were prescribed sodium-glucose co-transporter 2 inhibitors.
American Association Of Clinical Endocrinology 2021 News
A team of researchers assessed clinical, biochemical, and imaging features of patients with subacute thyroiditis after resolution of COVID-19 infection.
A team of investigators sought to identify sociodemographic disparities associated with the treatment of hypothyroidism.
This retrospective cohort study assessed hospitalized patients with diabetes to see if the new ISF-based scales improved glycemic control vs a traditional single sliding scale.
With the rate of a second fracture in high-risk patients still unknown, researchers evaluated the recurrence of fx in certain vulnerable subgroups.
Researchers investigate whether asymptomatic atherosclerotic CVD can be prevented with an aggressive medical treatment that reduces LDL cholesterol to <60 mg/dl.
A team of investigators sought to identify the impact of hyperglycemia on the severity of and outcomes associated with stroke in patients with type 2 diabetes.
A team of investigators conducted a study to determine the effect of short-term energy restriction in the form of reduced caloric intake and/or increased exercise on appetite among young women.
A team of investigators sought to assess the effectiveness of physician-directed weight loss program in the primary care setting.
A team of investigators conducted a study to estimate the clinical and economic consequences thyroid eye disease.
Researchers conducted an open-label, randomized controlled trial to evaluate methods guiding a successful transition from insulin pump to multiple daily injections of insulin degludec in patients with type 1 diabetes.
A team of investigators conducted a retrospective cohort study to determine the effect of protein caloric malnutrition on morbidity, mortality, and length of hospital stay in patients with thyrotoxicosis.
A team of investigators conducted a phase 3, multicenter study with a double-blind, randomized withdrawal period to assess the effects of twice-daily osilodrostat in patients with Cushing disease.
A team of investigators reviewed data from the 2018 Nationwide Inpatient Sample to assess the impact of obesity on outcomes in patients hospitalized for adrenal insufficiency.
The use of a digital therapeutics platform in people with obesity and metabolic syndrome can lead to a reduction in both weight and body mass index (BMI), thereby reducing risk for comorbidities, according to study results presented at the 30th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (ENVISION 2021). Digital…
Researchers presented a secondary analysis of data from a phase 3 trial evaluating 6-month subcutaneous leuprolide acetate 45 mg therapy for central precocious puberty.
Researchers discussed challenges and preventive strategies for clinicians to detect and manage patients with mild TBI-induced growth hormone deficiency.
A team of researchers assessed laboratory parameters in patients undergoing gender-affirming hormone therapy.
A team of researchers from Brown University and Harvard Medical School analyzed data from patients who were hospitalized with COVID-19.
Researchers from Duke University Health System reported findings from their study assessing care among adolescents and young adults with type 1 diabetes during their transition from pediatric to adult care.
Investigators report results from MAESTRO-NAFLD-1, a phase 3, randomized, double-blind, placebo-controlled trial evaluating the effect of treatment with resmetirom in patients with hypothyroidism and nonalcoholic steatohepatitis.
Researchers report the results of a systematic review assessing risk factors for peripheral artery disease in populations with type 2 diabetes.
Investigators report on a post hoc subgroup analysis of the STEP 3 trial that assessed the impact of semaglutide and intensive lifestyle modification on weight loss.
A post hoc analysis of the phase 3 ACTIVE trial of abaloparatide for fracture prevention in postmenopausal women was presented at ENVISION, the 2021 AACE Annual Meeting.